David Raulet

16PUBLICATIONS
74CO-AUTHORS
Molecular targetsBiologically active moleculesTumour immunologyInnate immunityEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 29, 2026
ITPKB is a conserved regulator of natural killer cell desensitization/education that constrains antitumor immunity.

|Jul 10, 2026
Viral capsid delivery of cGAMP enhances STING-dependent antitumor immune response.

|Apr 10, 2026
Intratumoral Treg cell ablation elicits NK cell-mediated control of CD8 T cell-resistant tumors.

Chenyu Zhang, Charles Chien, Eglė Jurgaitytė

|Feb 19, 2026
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics.

Grayson E Rodriguez, Yang Zhao, Yoko Nishiga

|Jul 16, 2025
Intra-Tumoral Treg Ablation Unleashes NK Cell-Mediated Control of CD8 T Cell-Resistant Tumors.

Chenyu Zhang, Charles Chien, Eglė Jurgaitytė

|May 16, 2025
Comparative evaluation of CAR-expressing T-, NK-, NKT-cells, and macrophages in an immunocompetent mouse glioma model.

Ryusuke Hatae, Payal B Watchmaker, Akane Yamamichi

Pageof 3

Frequent Collaborators

4 joint publications

Chenyu Zhang

3 joint publications

Yeara Jo

3 joint publications

K Christopher Garcia

2 joint publications

Elizabeth Andrews